AXSM vs. CORT
Compare and contrast key facts about Axsome Therapeutics, Inc. (AXSM) and Corcept Therapeutics Incorporated (CORT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AXSM or CORT.
Correlation
The correlation between AXSM and CORT is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AXSM vs. CORT - Performance Comparison
Loading data...
Key characteristics
AXSM:
0.91
CORT:
1.38
AXSM:
1.75
CORT:
3.90
AXSM:
1.20
CORT:
1.53
AXSM:
1.29
CORT:
3.71
AXSM:
4.03
CORT:
9.97
AXSM:
10.58%
CORT:
16.93%
AXSM:
45.88%
CORT:
122.36%
AXSM:
-86.65%
CORT:
-94.28%
AXSM:
-21.38%
CORT:
-34.49%
Fundamentals
AXSM:
$5.29B
CORT:
$7.96B
AXSM:
-$5.77
CORT:
$1.15
AXSM:
0.00
CORT:
0.61
AXSM:
12.25
CORT:
11.62
AXSM:
99.51
CORT:
11.65
AXSM:
$432.16M
CORT:
$685.45M
AXSM:
$395.36M
CORT:
$674.70M
AXSM:
-$266.14M
CORT:
$111.33M
Returns By Period
In the year-to-date period, AXSM achieves a 28.00% return, which is significantly lower than CORT's 48.48% return.
AXSM
28.00%
3.68%
17.14%
41.49%
50.69%
4.98%
N/A
CORT
48.48%
20.21%
42.19%
166.36%
54.17%
37.94%
29.05%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AXSM vs. CORT — Risk-Adjusted Performance Rank
AXSM
CORT
AXSM vs. CORT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Axsome Therapeutics, Inc. (AXSM) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
AXSM vs. CORT - Dividend Comparison
Neither AXSM nor CORT has paid dividends to shareholders.
Drawdowns
AXSM vs. CORT - Drawdown Comparison
The maximum AXSM drawdown since its inception was -86.65%, smaller than the maximum CORT drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for AXSM and CORT. For additional features, visit the drawdowns tool.
Loading data...
Volatility
AXSM vs. CORT - Volatility Comparison
The current volatility for Axsome Therapeutics, Inc. (AXSM) is 9.58%, while Corcept Therapeutics Incorporated (CORT) has a volatility of 11.55%. This indicates that AXSM experiences smaller price fluctuations and is considered to be less risky than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
AXSM vs. CORT - Financials Comparison
This section allows you to compare key financial metrics between Axsome Therapeutics, Inc. and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AXSM vs. CORT - Profitability Comparison
AXSM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Axsome Therapeutics, Inc. reported a gross profit of 111.67M and revenue of 121.46M. Therefore, the gross margin over that period was 91.9%.
CORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported a gross profit of 154.81M and revenue of 157.21M. Therefore, the gross margin over that period was 98.5%.
AXSM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Axsome Therapeutics, Inc. reported an operating income of -56.98M and revenue of 121.46M, resulting in an operating margin of -46.9%.
CORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported an operating income of 3.42M and revenue of 157.21M, resulting in an operating margin of 2.2%.
AXSM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Axsome Therapeutics, Inc. reported a net income of -59.41M and revenue of 121.46M, resulting in a net margin of -48.9%.
CORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported a net income of 20.29M and revenue of 157.21M, resulting in a net margin of 12.9%.